Company intelligence / Profile preview

Apotheca Biosolutions

Saint Petersburg, Florida, United Statesfda.gov ↗

Ownership: Private
Development stage: Other

Overview

Formerly developed and marketed medical-grade CBD products and nutraceuticals using proprietary transdermal, sublingual, and nasal cannabinoid delivery technologies. Focused on research into cannabinoid receptiveness in patients. No published clinical trial results or late-stage pharmaceutical programs identified.

Therapeutic areas: Neurology
Modalities: Transdermal delivery (patches)Sublingual delivery systemsNasal delivery systems
Industry: Food & Nutrition

Drug pipeline

3 assets

OTO-104

Phase 2

Indications: Meniere's disease

2 more assets in the full pipeline.

Request access →

Partnerships

LOI to acquire Nano Creaciones S.A. P.I. de C.V was announced but unclear if completed.

Beyond the preview

Go deeper on Apotheca Biosolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apotheca Biosolutions.

Explore the full profile